Estradiol (E 2 ) is normally metabolized to hydroxyestradiols and methoxyestradiols by CYP1A1, CYP1B1 and COMT. However, an altered production of these metabolites by a disturbed expression of these enzymes is associated with reproductive and non-reproductive pathologies. In vitro studies suggest that increased hydroxyestradiols and methoxyestradiols intratesticular generation is related to male infertility, but no studies have explored whether infertile men have a disturbed testicular expression of the enzymes that generate these E 2 metabolites. The aim of this study was to assess CYP1A1, CYP1B1 and COMT testicular expression at mRNA and protein level in men with spermatogenic impairment. Seventeen men with primary spermatogenic failure (13 with Sertoli cellonly syndrome and four with maturation arrest) and nine controls with normal spermatogenesis were subjected to testicular biopsy. mRNA was quantified using real-time RT-PCR and protein expression was evaluated using western blot and immunohistochemistry followed by integrated optic density analysis. Besides, the effects of hydroxyestradiols and methoxyestradiols on testosteroneinduced transcriptional activity were evaluated in TM4 cells using a luciferase reporter assay system. Our results show that patients with Sertoli cell-only syndrome had significantly elevated COMT expression at the mRNA level, higher COMT immunoreactivity in their seminiferous tubules and increased protein expression of the soluble COMT isoform (S-COMT), whereas patients with maturation arrest had significantly elevated CYP1A1 mRNA levels and higher CYP1A1 immunoreactivity in interstitial space. Finally, 2-hydroxyestradiol decreased testosterone-induced transcriptional activity in Sertoli cells in vitro. In conclusion, male infertility is related to disturbed testicular expression of the enzymes responsible for producing hydroxyestradiols and/or methoxyestradiols. If these changes are related with increased intratesticular hydroxyestradiols and methoxyestradiols concentrations, they could elicit an impaired Sertoli cell function. Our results suggest CYP1A1 and COMT as new potential targets in treating male infertility.
INTRODUCTION
Estradiol (E 2 ) is a pleiotropic hormone normally produced in the mammalian testis from testosterone (T) by the enzyme cytochrome P450 aromatase, which is expressed in Sertoli, Leydig and germ cells (Lardone et al., 2010) . E 2 exerts direct physiological effects on these cells to trigger a complete and correct spermatogenesis. For instance, E 2 regulates T production in Leydig cells (Vaucher et al., 2014) and ionic homeostasis in Sertoli cells (Bernardino et al., 2016) , and it acts as a survival factor for germ cells (Pentikainen et al., 2000) . However, the fact of high E 2 concentrations negatively affect the viability of germ cells altering the expression of factors related to apoptosis, such as SCF, c-kit, FasL, FasR, Bcl-2 and Bax (Nair & Shaha, 2003; Mishra & Shaha, 2005; Correia et al., 2014 Correia et al., , 2015 and that infertile men have high serum, seminal plasma and/or intratesticular E 2 concentrations compared to normozoospermic men (Pavlovich et al., 2001; Luboshitzky et al., 2002; Lardone et al., 2010 Lardone et al., , 2017 indicate that increased E 2 generation is associated to male infertility. E 2 is mainly inactivated in the liver by different conjugation and oxidation enzymatic reactions including sulfations, glucuronidations, hydroxylations and methylations (Zhu & Conney, 1998) . However, several extra-hepatic organs also express the enzymes required to inactivate E 2 (Zhu & Conney, 1998) . The most-studied peripheral E 2 inactivation pathways are conversion to hydroxyestradiols and methoxyestradiols. During these processes, the enzymes cytochrome P450 isoform 1A1 (CYP1A1) or 1B1 (CYP1B1) add a hydroxyl group in position 2 or 4, to generate 2-hydroxyestradiol (2OHE 2 ) or 4-hydroxyestradiol (4OHE 2 ), respectively (Dawling et al., 2004) . The enzyme catechol-Omethyltransferase (COMT) then replaces the hydroxyl group with a methyl group, to produce 2-methoxyestradiol (2ME 2 ) from 2OHE 2 or 4-methoxyestradiol (4ME 2 ) from 4OHE 2 (Dawling et al., 2004) . Interestingly, it has been demonstrated that these E 2 metabolites are not inactive compounds, but they play a crucial role in physiological and pathological conditions. For instance, E 2 exerts its anti-mitogenic effect in vascular muscle cells through its conversion to 2ME 2 (Zacharia et al., 2003; Dubey et al., 2005) , and the etiology of some hormone-related cancers, such as breast and prostate cancer, may be associated with high E 2 levels, increased CYP1A1 and/or CYP1B1 expression and consequently an elevated E 2 -to-hydroxyestradiol transformation rate (Cavalieri et al., 2002; Crooke et al., 2011; Mosli et al., 2013; Go et al., 2015; He & Feng, 2015) .
In terms of the male gonad, studies indicate that hydroxyestradiols and methoxyestradiols would be normally produced in this organ from E 2 (Axelrod & Goldzieher, 1962; Watanabe & Yoshizawa, 1987; Almadhidi et al., 1996) . However, it has been hypothesized that increased intratesticular concentrations of hydroxyestradiols and methoxyestradiols may be associated with severe alterations in spermatogenesis process, given that high 2OHE 2 and 4OHE 2 concentrations decrease the viability of mouse round spermatids and human spermatozoa in vitro (Bennetts et al., 2008; Aitken et al., 2013) . Besides, our group recently showed that high 2OHE 2 and 2ME 2 concentrations also negatively affect the viability of somatic testicular cells, as these E 2 metabolites induce DNA fragmentation in human and mouse Sertoli cells in vitro (Valencia et al., 2016) . Regarding human male infertility, genetic studies have shown an association between idiopathic male infertility and the presence of polymorphisms in CYP1A1 gene related to higher mRNA stability and increase enzymatic activity of this protein (Su et al., 2010; Luo et al., 2014) . However, no studies have explored whether infertile men have a disturbed CYP1A1, CYP1B1 and COMT testicular expression.
The aim of this study was to explore testicular expression of CYP1A1, CYP1B1 and COMT in men with maturation arrest (MA) and Sertoli cell-only syndrome (SCOS), two of the most severe forms of male infertility related with a primary spermatogenic failure. We also explored whether E 2 metabolites produced by CYP1A1, CYP1B1 and COMT impair Sertoli cell function, evaluating whether 2OHE 2 , 4OHE 2 , 2ME 2 and 4ME 2 at nanomolar concentrations affect the transcriptional activity induced by T in Sertoli cells in vitro.
MATERIALS AND METHODS

Patients and samples
A total of 26 subjects with azoospermia or oligozoospermia were included in this study. Seventeen subjects were diagnosed with a primary spermatogenic failure [13 with SCOS and four with MA at the spermatocyte stage (MA)] and nine with normal spermatogenesis (NS). Diagnosis was performed through a qualitative and quantitative histological evaluation of the germinal epithelium of 20 seminiferous tubules (Johnsen, 1970; Jezek et al., 1998 ) from a testicular sample, obtained by biopsy for sperm retrieval at the Institute of Maternal and Child Research, University of Chile. Besides, spermatozoa were recovered in men with NS for assisted reproductive technologies, which confirm that these patients had a normal spermatogenic process and that azoospermia was explained by obstructive causes (obstructive azoospermia). Extra testicular tissue was obtained during sperm retrieval to perform this study.
This study was approved by the Institutional Review Board of the University of Chile School of Medicine and the Ethics Committee of the Chilean Ministry of Health's Central Metropolitan Health Services. All subjects gave their written informed consent prior to sperm retrieval surgery. Patients with abnormal karyotypes, Y chromosome microdeletions, hypogonadotropic hypogonadism or serious chronic disease were excluded from the study, in addition to those undergoing hormonal treatments or who declared excessive consumption of alcohol or drugs.
RNA extraction and quantitative real-time PCR analysis
Total RNA was extracted using the RNeasy Mini kit (Qiagen, Hilden, Germany) from a testicular tissue sample adjacent to the section used for histological diagnosis. RNA quality was assessed using the 2100 BioAnalyzer with the Agilent RNA 6000 Pico kit (Agilent Inc, Santa Clara, CA, USA). Complementary DNA (cDNA) was synthesized from 1 lg total RNA using RevertAid H Minus Reverse Transcriptase (Thermo Scientific, Waltham, MA, USA) in a final volume of 20 lL following manufacturer specifications. Real-time PCR was performed using a LightCycler Nano RealTime PCR System (Roche Diagnostics, Mannheim, Germany). The PCR mixture for each reaction contained 10 lL FastStart Essential DNA Green Master (Roche Diagnostics), 1 lL of each primer (4 lmol/L) and 0.2 lL of cDNA. Final volume was adjusted to 20 lL with dH 2 O. The following thermal cycle program was applied to CYP1A1, CYP1B1 and COMT reactions: 95°C for 10 min; followed by 45 cycles of 95°C for 15 sec, 60°C for 30 sec and 72°C for 35 sec. The thermal cycle program used for the Gapdh reaction was: 95°C for 10 min, followed by 45 cycles of 95°C for 30 sec, 60°C for 30 sec and 72°C for 30 sec. All reactions were performed in duplicate. Primer sequences used in this study are shown in 5 0 -3 0 format as follows: CYP1A1, CAC-CATCCCCCACAGCAC and ACAAAGACACAACGCCCCTT; CYP1B1, GCTGCAGTGGCTGCTCCT and CCCACGACCTGATCCAATTCT; COMT, GCTACTGGCTGACAACGTGAT and CAGGAACGATTGGT AGTGTGTG; GAPDH, TGCCAAATATGATGACATCAAGAA and GG AGTGGGTGTCGCTGTTG. These primers have been used previously in other studies (Birkenkamp-Demtroder et al., 2002; Li et al., 2010; Lin et al., 2013) . The data obtained were analyzed using Roche LightCycler Nano Software, version 1.0 (Roche Diagnostics). Quantitative analysis using GAPDH as a reference housekeeping gene was based on the relative quantification of each gene of interest in the testicular samples of each group, using the 2 ÀDCT method (Schmittgen & Livak, 2008) . GAPDH was chosen as housekeeping because our group previously reported that GAPDH testicular expression is not significantly different among patients with NS, MA and SCOS (Lardone et al., 2007) .
Immunohistochemistry
Immunohistochemistry was performed using a testicular tissue sample adjacent to the section used for histological diagnosis. Briefly, 4-lm-thick paraffin sections mounted on silanized slides were deparaffinized and the sections immersed in 10 mM citrate buffer (pH 6.0) and heated at 121°C for 7 min. Non-specific staining was avoided by incubating the sections with H 2 O 2 30% (diluted 1 : 10 in methanol) for 10 min, followed by successive incubation with bovine serum albumin (2% in phosphatebuffered saline) for 30 min and then with blocking solution (Histostain-SP Broad Spectrum, Zymed Laboratories; Invitrogen, San Francisco, CA, USA). Subsequently, sections were incubated at 37°C for 1 h with anti-CYP1A1 rabbit polyclonal antibody sc-20772 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-CYP1B1 antibody ab33586 (Abcam, Cambridge, UK) or anti-COMT rabbit antibody AB5873 (Millipore, Billerica, MA, USA). To assess the specificity of the immunoreaction, we omitted primary antibody or incubated samples with normal rabbit IgG (sc-2027; Santa Cruz Biotechnology) at the same concentration used for the various primary antibodies. Subsequently, broad spectrum biotinylated secondary antibody and streptavidin-horseradish peroxidase were used following manufacturer specifications (Histostain SP Broad Spectrum, Zymed Laboratories; Invitrogen). Finally, samples were counterstained with hematoxylin (Dako, Glostrup, Denmark) and mounted with Histomount Mounting Solution (Invitrogen). Samples were observed under an epifluorescence microscope (Olympus BX-51TF; Olympus Optical Co. Ltd, Tokyo, Japan) and the images captured using a CoolSNAP-Pro digital camera (Media Cybernetics, Silver Spring, MD, USA). Positive immunostaining for CYP1A1, CYP1B1 and COMT (brown) was separately quantified in the seminiferous tubules and interstitial space by scoring the integrated optical density (IOD) of 10 non-continuous fields in each section with commercial image analysis software (IMAGE-PRO PLUS 6.2; Media Cybernetics). This analysis has been previously used and validated to semi-quantify protein expression in human testicular samples (Tian et al., 2014; Liu et al., 2015) .
Western blot
Testicular proteins were obtained from the same sample used to obtain the RNA samples, according to a previously described protocol (Morse et al., 2006) . Briefly, the flow-through obtained after the first centrifugation step of the RNeasy mini column (Qiagen) was recovered. Then, four volumes were added to this solution and incubated at À20°C for 30 min. The sample was centrifuged at 10,000 g for 10 min at 4°C and the pellet air-dried for 5 min. Next, 100 lL of cold ethanol was added to the sample and incubated for 10 min at À20°C. The sample was centrifuged at 8000 g for 5 min at 4°C. The supernatant was discarded and the last two steps repeated twice. Finally, the pellet was air-dried and resuspended in buffer containing NaCl 120 mM, Tris (10 mM, pH 6,8), Nonidet P-40 1% (v/v) and SDS 1% (v/v), supplemented with a commercial protease inhibitor cocktail (Roche). The samples were stored at À20°C until use.
Proteins (10 lg) were separated on 10-12% SDS-PAGE slab gels in a Mini PROTEAN electrophoretic chamber (Bio-Rad, Hercules, CA, USA). Proteins resolved in the gels were electroblotted onto nitrocellulose membranes (Bio-Rad). The membranes were incubated with blocking solution (Tween-20 0.1% in TBS containing 5% non-fat dry milk) for 1 h and then incubated with antibodies anti-CYP1A1 (sc20772), anti-CYP1B1 (ab33586), anti-COMT (AB5873) or anti-GAPDH (sc-25778, Santa Cruz) in blocking solution in a humidified chamber overnight at 4°C. The blots were rinsed five times for 5 min each in TBS and incubated for 1 h in Tween-20 0.1% in TBS that contained horseradish peroxidase (HRP)-conjugated goat anti-rabbit (31460; Thermo Scientific, Rockford, IL, USA). HRP activity was detected using enhanced chemiluminescent substrate western blotting substrate (Thermo Scientific).
Evaluation of testosterone-induced transcriptional activity in Sertoli cells
To explore the effect of hydroxyestradiols and methoxyestradiols on testosterone-induced transcriptional activity in Sertoli cells, we used TM4 cells, a non-tumorigenic mouse Sertoli cell line. Briefly, TM4 cells purchased from American Tissue Culture Collection (Manassas, VA, USA) were seeded in a 96-well plate (7.0 9 10 3 cells) and transiently transfected with a pcDNA3.1 plasmid that expresses the mouse androgen receptor sequence (pcDNA-AR, kindly donated by Dr. Chawnshang Zhang from Rochester University, USA), with a commercial plasmid that expresses luciferase gene, whose promoter sequence possesses tandem androgen response elements (AREs, Cignal Pathway Reporter kit; Qiagen) and with a pGEN2 plasmid that contains b-galactosidase sequence (pGEN2-bgal, kindly donated by Dr. Cecilia Johnson from University of Chile) following a protocol previously described by Zhang et al. (2012) . Twenty-four hours after transfection, cells were treated with 10 nM T plus various concentrations of 2ME 2 , 4OHE 2 , 4ME 2 (Steraloids, Newport, RI, USA), 2OHE 2 (Sigma-Aldrich, St. Louis, MO, USA) or vehicle (EtOH 0.001%) for 20 h. Luciferase activity was then measured using the Firefly & Renilla Luciferase Assay Kit (Biotium, Hayward, CA, USA) according to manufacturer protocol. Luciferase activity for each experiment was normalized with b-galactosidase activity. Experiments were performed in triplicate.
Statistical analyses
The results are presented as mean AE SE. Differences among groups were evaluated using a Kruskal-Wallis test, followed by a Mann-Whitney test, with GRAPHPAD PRISM software, version 5.03 (GraphPad Software, Inc., La Jolla, CA, USA). p-Values < 0.05 were considered statistically significant.
RESULTS
Patient age and serum hormone levels
Age, body mass index (BMI) and serum hormone parameters for the three patient groups are summarized in Table 1 . No significant differences were found between groups for T or SHBG serum level, ages and BMI. However, men with SCOS had significantly higher FSH and LH levels than men with NS and MA (p < 0.05), whereas patients with MA had significantly higher E 2 levels than men with NS (p < 0.05).
CYP1A1, CYP1B1 and COMT mRNA expression in testicular samples from men with SCOS and MA Real-time qRT-PCR was performed to evaluate CYP1A1, CYP1B1 and COMT mRNA expression levels in the testicular samples. As shown in Fig. 1, patients higher CYP1A1 expression than patients with NS and SCOS and significantly lower COMT expression than patients with SCOS (p ˂ 0.05). On the other hand, patients with SCOS had significantly lower CYP1A1 expression than patients with NS and MA, but significantly higher COMT expression than patients with NS and MA. There were no between-group differences in CYP1B1.
CYP1A1, CYP1B1 and COMT immunolocalization and protein expression in the human testis
To determine the location of CYP1A1, CYP1B1 and COMT, we used immunohistochemistry to examine expression of these proteins in the testicular tissue sections (Fig. 2) . The three proteins showed a similar expression pattern in the three patients groups. However, there were some differences when immunostaining intensity was quantified separately in the seminiferous tubules and interstitial space (Fig. 3) . CYP1A1 was predominantly expressed in the apical zone of Sertoli cells and weakly in the cytoplasm of interstitial cells. Nevertheless, significantly increased immunostaining for this protein was found in interstitial space from patients with MA vs. patients with NS (Fig. 3B) . COMT was localized in the cytoplasm of Sertoli and interstitial cells, and its immunostaining was significantly increased in seminiferous tubules of patients with SCOS vs. patients with NS (Fig. 3E) . Finally, CYP1B1 was predominantly expressed in the cytoplasm of interstitial cells, and no differences in immunostaining intensity were found in interstitial space and seminiferous tubules among men with NS, MA and SCOS ( Fig. 3C and D) .
We also evaluated the expression of these proteins using western blot in the three patient groups. No differences were found in CYP1A1 and CYP1B1 protein levels among patients with NS, MA and SCOS (Fig. 4A and B) . Regarding COMT, both the S-COMT and M-COMT isoforms reported in the literature were detected in the three patients groups. Significantly increased S-COMT expression was found in patients with SCOS vs. patients with NS, whereas M-COMT expression was similar among the three groups (Fig. 4C) .
Effects of hydroxyestradiols and methoxyestradiols on testosterone-induced transcriptional activity in Sertoli cells
TM4 cells were transfected with a plasmid-containing luciferase gene whose promoter possesses AREs and subsequently treated with various doses of T (0.1-100 nM) for 20 h. Finally, we evaluated luciferase activity. Under these experimental conditions, 10 nM T induced the maximum response (Fig. 5A) .
The luciferase activity induced by 10 nM T alone was compared to activity in cells co-treated with this dose of T plus various doses of 2OHE 2 . Interestingly, co-treatment with 10 nM 2OHE 2 significantly decreased the response to T (Fig. 5B) . We also evaluated the effects of the other E 2 metabolites produced by the enzymes studied here. We found that co-treatment with 10 nM 4OHE 2 also significantly decreased response to T (Fig. 5D ), but co-treatment with different concentrations of 2ME 2 or 4ME 2 did not affect the response (Fig. 5C and E) . Finally, luciferase activity in cells treated only with Table 1 Ages, body mass index (BMI) and serum hormonal levels of patients with normal spermatogenesis (NS), maturation arrest (MA) and Sertoli cellonly syndrome (SCOS) included in this study Age (years) FSH ( 
DISCUSSION
In this study, we show that human male infertility is related to disturbed testicular expression of the enzymes that produce hydroxyestradiols and methoxyestradiols from E 2 , given that infertile men with MA and SCOS showed an increased expression of CYP1A1 and S-COMT, respectively.
Firstly, to our knowledge, this is the sole study that provides detailed information on the expression and location of CYP1A1, CYP1B1 and COMT in the human testis. A previous study reported CYP1A1 and CYP1B1 expression at mRNA levels only (Bieche et al., 2007) . Given the location of these enzymes, hydroxyestradiols and methoxyestradiols are thought to be produced in Leydig and Sertoli cells; however, E 2 is thought to be mainly metabolized to 4OHE 2 in Leydig cells, whereas E 2 is thought to be transformed to 2OHE 2 , mainly in the apical zone of Sertoli cells. 4ME 2 and 2ME 2 can be generated in Sertoli and Leydig cells, given that COMT is expressed in both cell types. Both COMT isoforms (M-COMT and S-COMT) are normally expressed in the human testis with a pattern similar to that observed in the brain, where the M-COMT isoform is more abundant than S-COMT (Chen et al., 2004) .
A limitation of this study is that hydroxyestradiol and methoxyestradiol concentrations were not determined to corroborate the status of testicular CYP1A1, CYP1B1 and COMT as functional enzymes. However, previous results suggest that 2OHE 2 and 2ME 2 , at least, are normally produced in the human testis by these enzymes, as the mammalian testis is capable of producing 2OHE 2 from E 2 (Watanabe & Yoshizawa, 1987) and 2ME 2 from 2OHE 2 (Axelrod & Goldzieher, 1962) in vitro. Moreover, the enzyme cytochrome P450 aromatase isolated from the testis has also the ability to produce 2OHE 2 from E 2 in vitro (Almadhidi et al., 1996) . Our group also recently determined that 2ME 2 is present in the semen of healthy normozoospermic men, reaching 56.6 AE 2.1 pg/mL (data not published).
Although it is clear that E 2 plays a physiological role in the mammalian testis, high E 2 concentrations induce deleterious effects on Sertoli, Leydig and germ cells (Vigueras-Villasenor et al., 2006; Walczak-Jedrzejowska et al., 2008 and infertile men have high E 2 intratesticular concentrations (Lardone et al., 2010 (Lardone et al., , 2017 . Interestingly, several pathologies associated with a hyperestrogenic environment are also associated with elevated 2OHE 2 and 4OHE 2 concentrations (Greenlee et al., 2007; Huang et al., 2012; Zhao et al., 2015) . These studies suggest that a mechanism by which a hyperestrogenic environment induces its deleterious effects involve a high 2OHE 2 and/or 4OHE 2 conversion rate from E 2 . We hypothesize that one of the mechanisms by which high E 2 intratesticular concentrations induce deleterious effects on somatic and germ cells may involve an increased intratesticular hydroxyestradiol and methoxyestradiol generation from E 2 , as infertile men have a disturbed CYP1A1 and COMT testicular expression and high hydroxyestradiols and methoxyestradiols concentrations induce deleterious effects in Sertoli cells (Valencia et al., 2016) .
Regarding SCOS, our results indicate elevated testicular COMT expression in these patients at the mRNA level as well as Figure 4 Representative western blots for CYP1A1 (A), CYP1B1 (B) and COMT (C) using testicular protein samples from patients with NS, MA and Sertoli cell-only syndrome (SCOS). GAPDH was used as a loading control. Densitometric quantification of relative CYP1A1, CYP1B1 and COMT protein levels normalized to GAPDH is also shown. *p < 0.05. Mann-Whitney test. MA, maturation arrest; NS, normal spermatogenesis. elevated S-COMT, but not M-COMT, at the protein level. COMT can produce both M-COMT and S-COMT proteins through activation of two different promoters (Mannisto & Kaakkola, 1999) . Previous studies have shown that S-COMT levels increase in the human placenta as pregnancy progresses (Shen et al., 2014) and that S-COMT levels are higher in cancerous human endometrium cells as compared to normal cells (Hevir et al., 2011) . However, the mechanisms underlying the increases in S-COMT have yet to be elucidated. Interestingly, enzymatic studies have shown that S-COMT is mainly responsible for producing methoxyestradiols from hydroxyestradiols, whereas M-COMT is primarily involved in catecholamines inactivation (Bai et al., 2007) , suggesting that increased S-COMT expression in patients with SCOS, would greatly favor the generation of 2ME 2 and 4ME 2 from E 2 , whose intratesticular levels are significantly increased in these patients (Lardone et al., 2017) . Our results also indicate that COMT (and probably S-COMT) levels may be elevated specifically in seminiferous tubules of patients with SCOS. Because SCOS patients have almost exclusively Sertoli cells in their seminiferous tubules, our results suggest that 2ME 2 and 4ME 2 concentrations would be particularly high in Sertoli cells of patients with SCOS. Increased 2ME 2 concentration would likely provoke severe damage in Sertoli cells, as high 2ME 2 concentrations induce DNA fragmentation in human and mouse Sertoli cells (Valencia et al., 2016) . Furthermore, the percentage of Sertoli cells with fragmented DNA in men with SCOS is significantly higher than in men with NS (Kim et al., 2007) .
Regarding MA, this study shows elevated CYP1A1 testicular expression at the mRNA level and increased immunoreactivity for this protein in interstitial space of these patients. However, western blotting did not reflect a significant increase in CYP1A1 protein levels, likely because of the indirect protocol used to obtain the protein samples. The mechanisms underlying the elevated CYP1A1 levels in interstitial space, and probably in Leydig cells, of patients with MA may involve genetic and/or environmental factors. Interestingly, diesel exhaust particles increase CYP1A1 expression in Leydig cells (Yoshida et al., 2007) , suggesting that exposure to various persistent organic pollutants may be one mechanism responsible for the elevated CYP1A1 levels in these patients.
If increased testicular CYP1A1 expression in MA is associated with increased intratesticular 2OHE 2 concentrations in these patients, it could also trigger a poor response to T in Sertoli cells, as our results show that 2OHE 2 significantly reduces testosterone-induced transcriptional activity in Sertoli cells in vitro. This idea is consistent with the fact that low or absent T-cell Figure 5 Effects of hydroxyestradiols and meth oxyestradiols on testosterone-induced transcriptional activity in Sertoli cells. TM4 cells were transfected with a plasmid that expresses the luciferase gene under the control of androgen response elements and then incubated with various doses of T for 20 h, and, finally, luciferase activity was measured (A). Another group of cells was co-incubated with 10 nM T plus various concentrations of 2OHE 2 (B), 2ME 2 (C), 4OHE 2 (D) or 4ME 2 (E). *p < 0.05 compared to control group; Mann-Whitney test.
492 Andrology, 2017, 5, 486-494 signaling in Sertoli cells is related to MA (De Gendt et al., 2004; Kato et al., 2014; Smith & Walker, 2014) . The mechanisms by which 2OHE 2 negatively affects T signaling in Sertoli cells would not require a functional estrogen receptor, as the effect was not blocked by ICI182780, an estrogen receptor antagonist (data not shown). Finally, we do not discard the possibility that the elevated CYP1A1 expression observed in patients with MA is related to a negative effect on spermatogenesis attributable mainly to decreased testicular E 2 bioavailability rather than significantly elevated intratesticular 2OHE 2 concentration.
In summary, human male infertility is related to a disturbed testicular expression of the estrogen-metabolizing enzymes CYP1A1 and COMT, given that men with Sertoli cell-only syndrome show elevated S-COMT expression in their seminiferous tubules, whereas men with maturation arrest show elevated CYP1A1 expression in testicular interstitial space. If elevated expression of these enzymes is related with high intratesticular 2OHE 2 and 2ME 2 concentrations, it could negatively affect the function and/or viability of Sertoli cells and therefore impair the spermatogenic process. Our results contribute to knowledge regarding human male infertility related with a primary spermatogenic failure and suggest CYP1A1 and COMT as new potential targets in treating male infertility.
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